We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: Merck Says Vytorin Works Better Than Zocor
Study: Merck Says Vytorin Works Better Than Zocor
March 22, 2006
Merck has released a study that shows Vytorin, a cholesterol-lowering combination drug marketed by Merck and Schering-Plough, is more effective than Merck’s stand-alone drug Zocor.